Activation of alloreactive natural killer cells is resistant to cyclosporine

Transplantation

Volumn 63, Issue 8, 1997, Pages 1138-1144

  Petersson, Eva ^a   Qi, Zhongquan ^a   Ekberg, Henrik ^a   Östraat, Öyvind ^a   Dohlsten, Mikael ^a,b   Hedlund, Gunnar ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b Pharmacia & Upjohn AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; RECOMBINANT INTERLEUKIN 2;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DOSE RESPONSE; EFFECTOR CELL; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; NATURAL KILLER CELL; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; RAT;

EID: 0030930996     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704270-00014     Document Type: Article

References (38)

1. - lymphocytes in mixed lymphocyte culture. J Exp Med 1988; 168: 2403.
2. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990; 172: 1589.
3. Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G. Evidence for a similar or a common mechanism for natural killer cell activity and resistance to hemapoietic grafts. Eur J Immunol 1977; 7: 655.
4. Öhlèn C, Kling G, Höglund P, et al. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 1989; 246: 666.
5. Dalianis T, Ährlund-Richter L. One explanation for F1 antiparent responses. Immunol Today 1992; 13: 248.
6. Lechler R, Lombardi G. Structural aspects of allorecognition. Curr Opin Immunol 1991; 3: 715.
7. Moretta L, Ciccone E, Moretta A, Höglund P, Öhle'n C, Kärre K. Allorecognition by NK cells: nonself or no self? Immunol Today 1992; 13: 300.
8. Yokoyama WM. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc Natl Acad Sci USA 1995; 92: 3081.
9. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL. Generation of allospecific natural killer cells across a polymorphism of HLA-C. Science 1993; 260: 1121.
10. Kurago ZB, Smith KD, Lutz CT. NK cell recognition of MHC class I: NK cells are sensitive to peptide-binding groove and surface α-helical mutations that affect T cells. Immunology 1995; 154: 2631.
11. + IL-2 activated natural killer cells. Nature 1992; 358: 66.
12. Moretta A, Vitale M, Bottino C, et al. p58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer cells. J Exp Med 1993; 178: 597.
13. Moretta A, Simona S, Vitale M, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995; 182: 875.
14. Vaage JT, Naper C, Lövik G, et al. Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens. J Exp Med 1994; 180: 641.
15. -) alloreactive cytolytic lymphocytes in the rat. Cell Immunol 1987; 105: 366.
16. Ericsson PO, Hanson J, Dohlsten M, Sjögren HO, Hiserodt JC, Hedlund G. In vivo induced allo-reactive natural killer cells. J Immunol 1992; 149: 1504.
17. Larsson EL. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol 1980; 124: 2828.
18. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK 506. Immunol Today 1992; 13: 136.
19. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 1987; 7: 4472.
20. Olausson M, Mjörnstedt L, Lindholm L. Non suture organ grafting to the neck vessels in rats. Acta Chir Scand 1984; 150: 463.
21. Petersson E, Östraat Ö, Ekberg H, et al. Allogeneic heart transplantation activates alloreactive NK cells. Cell Immunol 1997; 174: 25.
22. Pescovitz MD. Organ acceptance and rejection. Curr Opin Immunol 1992; 4: 577.
23. Chandler C, Passaro E. Transplant rejection. Arch Surg 1993; 128: 279.
24. Lanier LL. The role of natural killer cells in transplantation. Curr Opin Immunol 1995; 7: 626.
25. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 1992; 10: 189.
26. Lindholm A. Therapeutic monitoring of cyclosporin: an update. Eur J Clin Pharmacol 1991; 41: 273.
27. Pearce NW, Berger MF, Gurley KE, Spinelli A, Hall BM. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Transplantation 1993; 55: 380.
28. Versluis DJ, Metselaar HJ, Bijma AM, Vaessen LMB, Wenting GJ, Weimar W. The effect of long-term cyclosporin therapy on natural killer cell activity. Transplant Proc 1988; 2: 179.
29. Alamartine E, Sabido O, Berthoux FC. The influence of prophylactic immunosuppressive regimens on natural killer and lymphokine-activated killer cells in renal transplant recipients. Transplantation 1990; 50: 969.
30. Kosugi A, Shearer GM. Effect of cyclosporin A on lymphopoiesis: augmentation of the generation of natural killer cells in bone marrow transplanted mice treated with cyclosporin A. J Immunol 1991; 146: 1416.
31. Heslop BF, McNeilage LJ, Sengupta S. Allogeneic lymphocyte cytotoxicity in rats the effects of various pharmacological agents. Immunology 1984; 53: 43.
32. Kasain MT, Biron CA. Cyclosporin A inhibition of interleukin 2 gene expression but not natural killer cells proliferation after interferon induction in vivo. J Exp Med 1990; 171: 745.
33. Løvik G, Vaage JT, Naper C, Benestad HB, Rolstad B. Recruitment of alloreactive natural killer cells to the rat peritoneum by a transfected cell line secreting rat recombinant interleukin-2. J Immunol Methods 1995; 179: 59.
34. Hess AD, Colombani PM. Mechanism of action of cyclosporin: role of calmodulin, cyclophilin and other cyclosporin-binding proteins. Transplant Proc 1986; 2: 219.
35. Kahan BD, Yoshimura N, Pellis NR, et al. Pharmacodynamics of cyclosporine. Transplant Proc 1986; 6: 238.
36. Yoshimura N, Oka T, Ohmori Y, Aikawa I, Fukuda M, Kahan BD. Influence of in vivo cyclosporine on interleukin production in kidney transplant recipients. Transplant Proc 1987; 1: 1194.
37. - T-cell responses are suppressed. Immunology 1991; 73: 444.
38. Varkita K, Silvennoinen O, Hurme M. Asialo GM1-positive cells have the opposite role in the activation of alloreactive cytotoxic T lymphocytes, CTL responses in vitro and in vivo. Acta Pathol Microbiol Immunol 1989; 95: 141.